Don't look now, but the long-beaten-down biotech sector is making an impressive comebackThe segment plunged by more than 40% between late July 2015 and what appears to be a series of bottoms in 2016's first half, but has rebounded some 20% since thenBiotech gained about 10% in July alone, with much of the rally powered by an uptick in M&A activity...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.